A statistical reference containing data through 2013

1 IMMUNIZATION SUMMARYA statistical reference containingdata through 2013CD-ROMinside(The 2014 Edition)DISCLAIMER: The data in thisedition supersede all historicaldata previously published byUNICEF and WHO. iIMMUNIZATION SUMMARYA statistical reference containingdata through 2013ii Indicative prices ..viii Trends: Regional Maps: Global Notes on indicators and and and .. and African , Democratic Republic of Rica ..42C te d Republic .. Salvador.

2 54 Equatorial (Islamic Republic of) .. , Democratic People s Republic , Republic People s Democratic Islands .. (Federated States of) .. iiiGlossary of , the State ..134 Papua New .. Kitts and Saint Vincent and the Tome and Saudi Arab , United Republic former Yugoslav Republic of and Arab , Bolivarian Republic INTRODUCTIONT racking, evaluating and sharing information provides a vital tool for understanding immunization coverage.

3 Statistics on levels and trends are used to monitor the performance of services at local, national and international levels. They guide campaigns to eradicate polio, control measles and eliminate neonatal tetanus. They identify areas of weak system performance and reveal areas where focused attention and extra resources may be required. And, when deciding whether to introduce a vaccine, immunization levels and trends are one important numbers for a single vaccine can provide vital information for national and global action.

4 Coverage levels for the diphtheria and tetanus toxoid with pertussis containing vaccine (DTP), for example, are considered to be good indicators of health system performance. In addition, some funding agencies, such as the GAVI Alliance, often consider immunization coverage levels when reviewing applications for financial and technical support, although coverage estimates alone are insufficient to constitute a sole criterion for determining whether a national immunization programme has achieved certain performance reference book, jointly produced by the United Nations Children s Fund (UNICEF) and the World Health Organization (WHO)

5 , presents detailed statistics on the performance of national and district-level immunization systems in 195 countries and territories. It provides an overview of key aspects, including: Basic indicators from WHO and UNICEF, the United Nations Population Division and the World Bank for each country or territory. The latest prevalence of home-based vaccination records. Trends in national and territorial coverage for ten major antigens. v District-level performance in achieving coverage with DTP and measles containing vaccines.

6 The most current immunization schedule reported by each country or copy of the most recent data collection form along with electronic copies of the book, background documentation, and data can be downloaded from UNICEF s statistical data web site at of the background documents and data can also be downloaded from the WHO website at viiANNUAL UPDATES viii Vaccine(doses per vial)BCGBCG-20 DTDT-10 DTPDTP-10 DTPHepHibDTP-HepB-Hib-1 (Liquid) (GAVI)DTP-HepB-Hib-1 (Liquid) (non GAVI)DTP-HepB+Hib-2 (Liophylized) (GAVI)DTP-HepB+Hib-2 (Liophylized) (non-GAVI)DTP-HepB-Hib-10 (Liquid) (GAVI)DTP-HepB-Hib-10 (Liquid) (non GAVI)DTPHibDTP+Hib-1 (Liophylized) (non-GAVI)DTP-Hib-10 (Liquid) (GAVI/non-GAVI)DTP+Hib-10 (Liophylized) (GAVI)DTP+Hib-10 (Liophylized) (non GAVI)DTP-Hib-10 (Liquid) (non GAVI)HepBHepB-1 HepB-10 HibHib-1 (Liquid) (non-GAVI)Hib-1 (Liophylized)Hib-10 (Liquid)HPVHPV2-2 (GAVI)HPV4-1 (GAVI)

7 InfluenzaInfluenza-1 Influenza-10 MCVMea-10 MeningitisMeningitis A Conj-10 Meningitis AC PS-10 Meningitis ACYW PS-10 MMRMMR-1 (L-Zagreb strain)MMRx-1 (Urabe strain)MMR-2 (Jeryl Lyn)MMR-5 (L-Zagreb strain)MMR-10 (Urabe strain)MMR-10 (L-Zagreb strain)MRMR-10 IPVIPV-1bOPVbOPV-20mOPVmOPV1-20tOPVtOPV- 10tOPV-20 PneumococcalPCV13-1 (GAVI)PCV10-2 (GAVI)RabiesRabies-1 RotavirusRV1-1 (GAVI)*RV5-1 (GAVI)TdTd-10 TTTT-10TT-20 Yellow feverYF-5YF-10 (GAVI)YF-10 (non-GAVI)YF-20 Table 1: Indicative budget prices for major antigens, 2014 The prices listed in the table below are subject to change.

8 UNICEF Supply Division provides this information for preliminary budget planning only. Full names of these vaccines appear in the Glossary of Acronyms, p. 197.* The price of RV1-1 vaccines contracted with supplier is EUR per dose. Therefore, the price in US$ will fluctuate throughout the year. The price indicated in this table is based on the UN rate of exchange as of 1 May 2013. ixRecommended budget price, 2014 (US$ per vial) (US$ per dose) availablenot availablenot availablenot availablenot availablenot availablenot availablenot availablenot availablenot availablenot availablenot availablenot availablenot availablenot availablenot availablenot Table 2: Indicative budget price for immunization devices, 2014 These prices are subject to change.

9 UNICEF Supply Division provides this information for preliminary budget planning (box of 100, unless otherwise stated)Recommended budget price, 2014 (US$ per box)BCG autodisable syringe, autodisable syringe, syringe, syringe, 2 ml, with prevention feature syringe, 2 ml, with fixed needle *Re-use prevention feature syringe with SIP, 3 ml, with fixed *Reconstitution syringe, 5 ml, with prevention feature syringe, 5 ml, with fixed needle prevention feature syringe with SIP, 5 ml, with fixed syringe, 10 ml, with needle prevention feature syringe, 10 ml, with fixed box, 5 l (box of 25) * FCA price.

10 XiTRENDS: REGIONAL PROGRESS TOWARDS MDG4, 1980 - 2013 Note: The list of countries and territories in MDG regions appears online at the United Nations Statistics Division website Millennium Development Goals Indicators < > xii MCV1 Coverage20132012201120102009200820072006 2005200420032002200120001999199819971996 19951994199319921991199019851980 Global8483838483828080767775737373727271 737372706969734816 MDG regionsCaucasus and Central countries9394939292949494939393939292919 090908886838283848063 Eastern Asia999999999997949387878686868484828283 807682879298871 Latin